Keep an Eye on Safety When Choosing Holiday Gifts
Air, BB, pellet and paintball guns may be on children’s holiday wish lists, but are they safe? Eye Injuries from Projectile Toys on the Rise Eye injuries from these types of guns
read more
Dr. Abbey Discusses New Treatment for Macular Telangiectasia Type 2
At AAO 2025, the American Academy of Ophthalmology’s annual meeting, Texas Retina’s Dr. Ashkan Abbey moderated a case-based roundtable discussion about the evolving landscape of macular telangiectasia (MacTel) type 2 care, including
read more
Happy Thanksgiving!
All Texas Retina Associates offices will be closed Thursday, November 27, and Friday, November 28, for the Thanksgiving holiday. During this time of reflection and gratitude, we want you to know how
read more
How Smoking Can Affect Your Eye Health
Today is the Great American Smokeout. Smoking remains the single largest cause of preventable disease and premature death in the United States. You probably know that smoking increases your risk of developing
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month and Diabetic Eye Disease Awareness Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood
read more
Dr. Abbey Doses First Patient in Phase 1b/2a LOTUS-2 Clinical Trial of Novel Multivalent Fusion Antibody EB-105 for Diabetic Macular Edema
On October 28, 2025, Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, dosed the first patient in the Phase 1b/2a LOTUS-2 clinical trial of novel multivalent fusion antibody (EB-105) for diabetic
read more
Dr. Rene Choi Inducted into International Retina Imaging Society
Texas Retina’s Rene Y. Choi, MD, PhD, was inducted into the prestigious International Retina Imaging Society (IntRIS) on October 29, 2025. A private, nonprofit professional membership society, the mission of IntRIS is
read more
Dr. Ashkan Abbey Presented at the American Academy of Ophthalmology Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented, taught and served as a panelist at AAO 2025, the American Academy of Ophthalmology’s annual meeting held in Orlando, Florida, October 18-20, 2025. Highlights of
read more
Texas Retina’s Dr. Rene Choi Receives “One to Watch” Award at AAO 2025
“Dr. Rene Choi is an exceptional ophthalmologist, distinguished by his unwavering integrity and outstanding kindness and compassion towards his patients. He combines superb clinical and surgical skills in treating retinal and inflammatory
read more
Texas Retina Participating in New Phase III Clinical Trial for Uveal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina will soon begin enrolling patients in the OptimUM-10 clinical trial, a randomized, Phase III, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic
read more